The Systemic Immune-Inflammation Index as an Innovative Prognostic Indicator for Critically Ill Sepsis Patients: Insights from the MIMIC-IV Database and Machine Learning Predictive Analysis - Scorecard - MDSpire

The Systemic Immune-Inflammation Index as an Innovative Prognostic Indicator for Critically Ill Sepsis Patients: Insights from the MIMIC-IV Database and Machine Learning Predictive Analysis

  • By

  • Xudong Zhang

  • Yiquan Xu

  • Yu Lei

  • Miaomiao Tang

  • Yanqing Wang

  • Jianghui Luo

  • Shuying Zhu

  • February 7, 2026

  • 0 min

Share

Clinical Scorecard: The Systemic Immune-Inflammation Index as an Innovative Prognostic Indicator for Critically Ill Sepsis Patients: Insights from the MIMIC-IV Database and Machine Learning Predictive Analysis

At a Glance

CategoryDetail
ConditionSepsis
Key MechanismsDysregulated host response to infection leading to systemic inflammation and immune dysfunction.
Target PopulationCritically ill patients aged 18 years or older with sepsis.
Care SettingIntensive Care Units (ICUs)

Key Highlights

  • SII index calculated as (neutrophil × platelet)/lymphocyte serves as a prognostic marker.
  • High early mortality in sepsis, with one-third of deaths occurring within the first 48 hours of ICU admission.
  • SII reflects immune-inflammatory imbalance and may enhance risk stratification in sepsis.

Guideline-Based Recommendations

Diagnosis

  • Identify sepsis using ICD-9 and ICD-10 codes.

Management

  • Utilize SII for risk stratification and guiding early clinical interventions.

Monitoring & Follow-up

  • Monitor SII alongside traditional severity scores for better prognostic insight.

Risks

  • Patients with low lymphocyte counts and high neutrophil and platelet counts have poorer outcomes.

Patient & Prescribing Data

4001 patients with sepsis enrolled from MIMIC-IV database.

SII may inform treatment decisions and predict mortality risk.

Clinical Best Practices

  • Incorporate SII in routine assessments for critically ill septic patients.
  • Combine SII with other clinical scores for comprehensive risk evaluation.

References

Original Source(s)

Related Content